Risk factor
High price volatility
Profitability factor
Very favourable analyst view
About
Sino Medical Sciences Technology Inc. operates as a medical device enterprise, specializing in the research, development, manufacturing, and distribution of interventional medical devices throughout China. Its product portfolio features a range of crucial items, including drug-eluting stents, balloon catheters, coronary stents, and sophisticated transcatheter mitral valve replacement devices. Furthermore, the company maintains a clinical partnership with The National University of Ireland Galway. Established in 2007, its main operational base is situated in Tianjin, China.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB
Target Price
The average target price of 688108.SS is 24.0 and suggests 72% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i